Cargando…

Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix

The aim of the study was to evaluate VEGF expression in tumour biopsies as a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. A retrospective study was carried out on 100 patients. Pre-treatment tumour VEGF expression was examined immunohistochemically in formalin-fixe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loncaster, J A, Cooper, R A, Logue, J P, Davidson, S E, Hunter, R D, West, C M L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363503/ https://www.ncbi.nlm.nih.gov/pubmed/10944602 http://dx.doi.org/10.1054/bjoc.2000.1319

Ejemplares similares

Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
por: Cooper, R A, et al.
Publicado: (1999)

Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumour oxygenation during radiotherapy
por: Sheridan, M T, et al.
Publicado: (2000)

The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix.
por: West, C. M., et al.
Publicado: (1997)

Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas
por: Mineta, H, et al.
Publicado: (2000)

Expression of the proapoptotic protein Bid is an adverse prognostic factor for radiotherapy outcome in carcinoma of the cervix
por: Green, M M L, et al.
Publicado: (2005)

Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?
por: Linderholm, B, et al.
Publicado: (1999)

No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix
por: Kabuubi, P, et al.
Publicado: (2006)

Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers
por: Fujimoto, J, et al.
Publicado: (1999)

Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
por: Akagi, K, et al.
Publicado: (2000)

Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix.
por: West, C. M., et al.
Publicado: (1993)

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells
por: Pidgeon, G P, et al.
Publicado: (2001)

Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy.
por: Sproston, A. R., et al.
Publicado: (1995)

The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts
por: Danielsen, T, et al.
Publicado: (2000)

Expression of Ku70 correlates with survival in carcinoma of the cervix
por: Wilson, C R, et al.
Publicado: (2000)

A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines
por: Chiarotto, J A, et al.
Publicado: (1999)

Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value
por: Herrlinger, U, et al.
Publicado: (2004)

Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma
por: Shen, G H, et al.
Publicado: (2000)

Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas
por: Yudoh, K, et al.
Publicado: (2001)

Vascular endothelial growth factor A (VEGF-A) mRNA expression levels decrease after menopause in normal breast tissue but not in breast cancer lesions
por: Greb, R R, et al.
Publicado: (1999)

Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer
por: West, A F, et al.
Publicado: (2001)

A Maternally Sequestered, Biopolymer‐Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia
por: Logue, Omar C., et al.
Publicado: (2017)

Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer
por: Coradini, D, et al.
Publicado: (2001)

Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells
por: Chen, H J, et al.
Publicado: (2000)

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
por: O'Byrne, K J, et al.
Publicado: (2000)

Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat
por: Xie, B, et al.
Publicado: (1999)

VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
por: Barratt, Shaney L., et al.
Publicado: (2018)

Carcinoma of the cervix
por: Resbeut, M, et al.
Publicado: (2001)

Prognostic Significance of Vascular Endothelial Growth Factor (VEGF) and Her-2 Protein in the Genesis of Cervical Carcinoma
por: Rahmani, Arshad H., et al.
Publicado: (2018)

Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours
por: Parliament, M B, et al.
Publicado: (2000)

The prognostic value of [(123)I]-vascular endothelial growth factor ([(123)I]-VEGF) in glioma
por: Rainer, Eva, et al.
Publicado: (2018)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.
por: Banks, R. E., et al.
Publicado: (1998)

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
por: Papadopoulos, Nicholas, et al.
Publicado: (2012)

Expression of vascular endothelial growth factor (VEGF) in equine sarcoid
por: Martano, Manuela, et al.
Publicado: (2018)

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
por: Shaheen, R M, et al.
Publicado: (2001)

The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease
por: Holmes, David IR, et al.
Publicado: (2005)

Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression
por: Crew, J P, et al.
Publicado: (2000)

Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer.
por: Obermair, A., et al.
Publicado: (1998)

Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers
por: Fujimoto, J, et al.
Publicado: (2001)

Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
por: Fontanini, G., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_kh29jmjglg0sbn2mta8fi6h54g